Effect of SGLT2 inhibitors on anemia and their possible clinical implications Aleix Cases; Secundino Cigarrán; José Luis Górriz; Julio Nuñez;

Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim;

Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease Jose Luis Górriz; José Ramón González-Juanatey; Lorenzo Facila; Maria Jose Soler; Alfonso Valle; Alberto Ortiz;